To conduct the study, the investigators obtained data on coffee consumption from genome‐wide association studies (GWAS) and ...

Funding will support continued product development, while the board is composed of “global leaders in posterior and anterior ...

A look at current therapies, clinical trial results, patient education, and emerging options for managing this progressive ...

Assistive devices empower patients with central vision loss to regain independence, enhancing daily activities and reducing ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

Effective treatment for Demodex blepharitis includes antibiotics, steroids, and lotilaner ophthalmic solution, which resolves ...

Optical coherence tomography markers—like the ellipsoid zone—are reshaping clinical trials in intermediate age-related ...

Eyecyte-RPE phase 1 study showed promising safety and efficacy, with no serious adverse events and significant vision ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

Aldeyra had received 2 complete response letters (CRL) from the FDA in April 2025 and November 2023 for past submissions.

The deep learning system distinguishes IIH, NAION, and healthy eyes with 93.6% accuracy, aiding in resource-limited settings.

The center aims to optimize patients' vision with a range of cataract and corneal refractive procedures and minimize reliance ...